Iron Mountain (IRM) › Analysis

Iron Mountain (IRM) stock analysis, November 13, 2026: Neutral stance, low conviction

Published November 13, 2026 · IRM chart, levels and live analysis

Iron Mountain Incorporated reported a strong earnings beat on November 5, but guidance fell short of expectations, leaving the shares at $114.58 after a 1.9% rise on the day. The balance of evidence points to a neutral outlook for the next two to six weeks, with low conviction and a downside breakout bias. The price sits just above the 50‑day average and below the 200‑day average, keeping the longer‑term trend down while the short‑term rally remains untested.

Why it matters

The Q3 2026 earnings release showed revenue of $2.0 billion, up 13.5% YoY, and adjusted EPS of $0.64, beating the $0.61 consensus. Management highlighted record adjusted EBITDA of $748 million and an all‑time high AFFO of $458 million. However, the company guided Q4 revenue below its own forecasts, a downgrade that immediately pressured the stock despite the beat. The market’s reaction was a modest 1.9% gain on the day, while the broader S&P 500 fell 0.35%, indicating the move was driven more by the stock’s own fundamentals than by sector momentum.

Over the past five days the stock outperformed the S&P 500 by 1.9 percentage points, a sign that the rally is still largely a stock‑specific response to earnings. Volume was 31.3% above the 20‑day average, suggesting active participation but not enough to sustain a longer trend. The sector backdrop is mixed: data‑center demand is under debate, with some analysts warning of a construction moratorium while others see continued growth. Those sector narratives have not yet filtered into IRM’s price action, which remains more tied to its own earnings story.

Analyst consensus remains a “buy” with a mean price target of $138.73, implying a 17.4% upside from the current price. The low end of the target range is $124, still above today’s level, but the spread reflects optimism that may be priced in already. The stock’s relative strength versus the S&P 500 over 50 days is +1.9%, but over 200 days it lags by –4.6%, underscoring the disconnect between short‑term momentum and the longer‑term downtrend.

Both sides of the debate agree that the earnings beat was real, but they differ on the significance of the weaker guidance. Proponents argue the record AFFO and EBITDA cushion the outlook, while skeptics point to the revenue miss and the fact that the price is still below its 40‑week average, keeping the long‑term thesis intact.

What the evidence says

On the long‑term horizon the downtrend remains intact: the price is still below its 40‑week average and the 200‑day SMA sits at $116.10, a level that has acted as resistance. The rally after earnings has not stretched the weekly downtrend; the stock is merely testing the swing‑zone resistance at $114.78, where sellers have historically stepped in.

For the next two to six weeks the balance of evidence leans neutral with low conviction. The assessment notes a rally against the weekly downtrend that is not yet stretched and a 50‑day SMA breakout that would require a daily close below $113.55 to confirm a downside move. The math shows a primary target at $109.69 (reward‑to‑risk 1.6) and a deeper target at $96.71 (reward‑to‑risk 7.1), meeting a 3‑to‑1 risk‑reward only on the deeper leg. The strongest case against a neutral reading would be a clean weekly close above the 200‑day SMA at $116.10, which would realign the price with the longer‑term trend; however, the current price of $114.58 is still below that threshold, keeping the downside bias in place.

Levels that matter

The structure holds above the swing‑zone level of $114.78, a zone where sellers have previously taken control on rallies. The weekly trend would be considered ended if the price closes above $116.10, the 200‑day SMA, signaling a potential shift in the longer‑term bias.

The breakout math focuses on a daily close below $113.55, the 50‑day SMA. A stop is placed at $115.92, derived from the swing‑zone at $114.78 plus a quarter of the 14‑day ATR ($4.54). The primary target of $109.69 rests on the swing‑zone support, offering a 1.6‑to‑1 reward‑to‑risk. A secondary target at $96.71 extends the move deeper into the swing‑zone, delivering a 7.1‑to‑1 reward‑to‑risk. Because the 3‑to‑1 criterion is only met on the deeper target, the math does not fully satisfy a high‑conviction breakout.

What would change the picture

A weekly close above $116.10, the 200‑day SMA, would invalidate the current neutral stance and suggest a shift toward a more positive bias. The non‑price factor that could trigger such a change is a revision to the Q4 revenue guidance that lifts the outlook above prior expectations, aligning earnings momentum with the longer‑term trend.

What to watch

Get a message when the IRM picture changes — the agent team watches the levels and the news for you.Create a free account

More IRM analyses

Research & education, not advice. MarketCrew is AI-powered and can make mistakes.